5-[2-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]ethoxy]-4-methyl-1,3-thiazole,dihydrochloride

Names

[ CAS No. ]:
136996-70-8

[ Name ]:
5-[2-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]ethoxy]-4-methyl-1,3-thiazole,dihydrochloride

[Synonym ]:
4-Methyl-5-(2-(4-(5-chloro-2-methylphenyl)piperazin-1-yl)ethoxy)thiazole dihydrochloride
5-[2-[4-(5-chloro-2-methylphenyl)piperazin-1-yl]ethoxy]-4-methyl-1,3-thiazole dihydrochloride
Piperazine,1-(5-chloro-2-methylphenyl)-4-(2-((4-methyl-5-thiazolyl)oxy)ethyl)-,dihydrochloride
B 1313

Chemical & Physical Properties

[ Molecular Formula ]:
C17H24Cl3N3OS

[ Molecular Weight ]:
424.81600

[ Exact Mass ]:
423.07100

[ PSA ]:
56.84000

[ LogP ]:
5.22120

[ Vapour Pressure ]:
1.92E-10mmHg at 25°C

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
TL1766924
CHEMICAL NAME :
Piperazine, 1-(5-chloro-2-methylphenyl)-4-(2-((4-methyl-5-thiazol yl)oxy)ethyl)-, dihydrochloride
CAS REGISTRY NUMBER :
136996-70-8
LAST UPDATED :
199612
DATA ITEMS CITED :
1
MOLECULAR FORMULA :
C17-H22-Cl-N3-O-S.2Cl-H
MOLECULAR WEIGHT :
424.85

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Oral
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
770 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5322846

Related Compounds

  • 3-(1-Aminopropan-2-YL)-2-methyloxolan-3-OL
  • 3-(2-Aminoethyl)-2-methyloxolan-3-ol
  • 3-(1-Amino-2-methylbutan-2-YL)-2-methyloxolan-3-OL
  • 4-Chloro-7-(4-nitrophenyl)-6-phenylpteridine
  • (3-Hydroxy-2-oxocyclohexyl) acetate
  • 4-Bromo-2-(4-methoxybut-1-enyl)-6-methylpyridine
  • 1-(4-Bromo-2-isobutoxy-phenyl)-ethylamine
  • 2-(p-Tolyl)but-1-en-1-one
  • 4-Bromo-N-(4-bromophenyl)-N-hexylbenzenamine
  • 2-Mercaptopyrimidine-4-carbonitrile
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.